Sanara Medtech
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $26,333 | $25,830 | $23,434 | $26,305 |
Gross Profit | 24,459 | 23,893 | 21,599 | 24,056 |
EBITDA | -27,982 | 1,082 | -1,085 | 1,196 |
EBIT | -28,593 | -31 | -2,210 | -411 |
Net Income | -30,411 | -2,014 | -3,527 | -1,538 |
Net Change In Cash | 26,333 | 25,830 | 23,434 | 26,305 |
Free Cash Flow | 1,116 | 902 | -3,721 | 836 |
Cash | 14,939 | 16,958 | 20,687 | 15,878 |
Basic Shares | 8,940 | 8,612 | 8,570 | 8,531 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $86,672 | $64,989 | $45,842 | $24,143 |
Gross Profit | 78,532 | 57,137 | 39,481 | 21,832 |
EBITDA | -1,860 | -289 | -11,566 | -7,221 |
EBIT | -6,783 | -3,964 | -13,937 | -7,993 |
Net Income | -9,664 | -4,303 | -7,937 | -7,921 |
Net Change In Cash | 86,672 | 64,989 | 45,842 | 24,143 |
Cost of Revenue | -9,693 | |||
Free Cash Flow | -253 | -3,510 | -6,301 | -5,564 |
Cash | 15,878 | 5,147 | 8,958 | 18,652 |
Basic Shares | 8,484 | 8,278 | 7,906 | 7,341 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$3.40 |
2025-06-30 | -$0.23 |
2025-03-31 | -$0.41 |
